LAG3 and non-small cell lung carcinoma: Moreover, Ding and colleagues reported that LAG-3 upregulation was found in five of eight patients with NSCLC presenting acquired resistance to ICIs, suggesting that there might be a role for anti-LAG3 in that setting [79].